Table 1.

Clinical-pathological characteristics of the glioma patients and LGALS3 expression.

	No. of cases	LGALS3		P
		Negative	Positive
Age				0.001
≤ 45	163	110	53
>45	141	69	72
Gender				0.237
Male	180	101	79
Female	124	78	46
WHO grade				<0.001
Low (I+II)	95	78	17
High (III+IV)	209	101	108
Location				0.615
Supratentorial	287	168	119
Subtentorial	17	11	6
IDH				<0.001
Wildtype	177	76	101
Mutated	127	103	24
ATRX				0.562
Wildtype	160	97	63
Mutated	144	82	62
1p/19q				0.002
Co-deleted	48	38	10
Intact	256	141	115
TERT				0.003
Wildtype	160	107	53
Mutated	144	72	72
MGMT				0.541
Promoter methylated	159	91	68
Promoter Unmethylated	145	88	57
P53				0.589
≤ 10%	110	67	43
>10%	194	112	82
PHH3				<0.001
≤ 5	123	95	28
>5	181	84	97
Ki67				<0.001
≤ 10%	74	57	17
>10%	230	122	108

Bold values represent p < 0.05.